PanTheryx Inc, a global nutrition company and Dr. Reddy's Laboratories Ltd, an Indian Pharmaceutical company announced today a multi-country supply and licensing agreement. The agreement grants Dr. Reddy's the exclusive right to market and distribute PanTheryx's breakthrough nutritional intervention, DiaResQ, for infectious diarrhoea in Asian countries under "RELIQUA" brand name.
DiaResQ helps promote intestinal repair and boost natural immune defenses, resulting in the restoration of normal digestive function. The product was recently recognized as one of the 30 leading healthcare innovations with great promise to transform global health by 2030.
